HCPCS Service Codes - Medical care

HCPCS Service Code 1 for Medical care.

HCPCS Type of Service (TOS) code is an indicator that the contractor places on Form CMS-1500. The indicator is mainly used for data purposes, however in some instances, it affects payment. All HCPCS codes have a corresponding TOS indicator.

Below are all available HCPCS TOS codes. Find an HCPCS code based on the type of service.

HCPCS Codes for Medical care

  • M1346

    Patients who did not have a net increase in pam score of at least 6 points within a 4 to 12 month period

  • M1347

    Patients who achieved a net increase in pam score of at least 3 points in a 4 to 12 month period (passing)

  • M1348

    Patients who achieved a net increase in pam score of at least 6-points in a 4 to 12 month period (excellent)

  • M1349

    Patients who did not have a net increase in pam score of at least 3 points within a 4 to 12 month period

  • M1350

    Patients who had a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter

  • M1351

    Patients who had a suicide safety plan initiated, reviewed, or updated and reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation

  • M1352

    Suicidal ideation and/or behavior symptoms based on the c-ssrs or equivalent assessment

  • M1353

    Patients who did not have a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter

  • M1354

    Patients who did not have a suicide safety plan initiated, reviewed, or updated or reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation

  • M1355

    Suicide risk based on their clinician's evaluation or a clinician-rated tool

  • M1356

    Patients who died during the measurement period

  • M1357

    Patients who had a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment

  • M1358

    Patients who did not have a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment

  • M1359

    Index assessment during the denominator period when the suicidal ideation and/or behavior symptoms or increased suicide risk by clinician determination occurs and a non-zero c-ssrs score is obtained

  • M1360

    Suicidal ideation and/or behavior symptoms based on the c-ssrs

  • M1361

    Suicide risk based on their clinician's evaluation or a clinician-rated tool

  • M1362

    Patients who died during the measurement period

  • M1363

    Patients who did not have a follow-up assessment within 120 days of the index assessment

  • M1364

    Calculated 10-year ascvd risk score of >= 20 percent during the performance period

  • M1365

    Patient encounter during the performance period with hospice and palliative care specialty code 17

  • M1366

    Focusing on women's health mips value pathway

  • M1367

    Quality care for the treatment of ear, nose, and throat disorders mips value pathway

  • M1368

    Prevention and treatment of infectious disorders including hepatitis c and hiv mips value pathway

  • M1369

    Quality care in mental health and substance use disorders mips value pathway

  • M1370

    Rehabilitative support for musculoskeletal care mips value pathway

  • M1371

    Most recent glycemic status assessment (hba1c or gmi) level < 7.0%

  • M1372

    Most recent glycemic status assessment (hba1c or gmi) level >= 7.0% and < 8.0%

  • M1373

    Most recent glycemic status assessment (hba1c or gmi) level >= 8.0% and <= 9.0%

  • M1374

    An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period

  • M1375

    An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period

  • M1376

    An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period

  • M1377

    Recommended follow-up interval for repeat colonoscopy of 10 years documented in colonoscopy report and communicated with patient

  • M1378

    Documentation of medical reason(s) for not recommending a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is >= 66 years old, or life expectancy < 10 years, other medical reasons)

  • M1379

    A 10 year follow-up interval for colonoscopy not recommended, reason not otherwise specified

  • M1380

    Filled at least two prescriptions during the performance period for any combination of the qualifying oral antipsychotic medications listed under "denominator note" or the long-acting injectable antipsychotic medications listed under "denominator note"

  • M1381

    Patients with secondary stroke (e.g., a subsequent stroke that may occur with vasospasm in the setting of subarachnoid hemorrhage) within 5 days of the initial procedure

  • M1382

    Patient encounter during the performance period with place of service code 11

  • M1383

    Acute pvd

  • M1384

    Patients who died during the performance period

  • M1385

    Documentation of patient reasons for patients who were not seen for the second pam survey (e.g., less than four months between baseline pam assessment and follow-up

  • M1386

    Patients with an excisional surgery for melanoma or melanoma in situ in the past 5 years with an initial ajcc staging of 0, i, or ii at the start of the performance period

  • M1387

    Patients who died during the performance period

  • M1388

    Patients with documentation of an exam performed for recurrence of melanoma

  • M1390

    Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period

  • M1391

    All patients who were diagnosed with recurrent melanoma during the current performance period

  • M1392

    Documentation of patient reasons for no examination, i.e., refusal of examination or lost to follow-up (documentation must include information that the clinician was unable to reach the patient by phone, mail or secure electronic mail - at least one method must be documented)

  • M1393

    Patients who were not diagnosed with recurrent melanoma during the current performance period

  • M1394

    Stages i-iii breast cancer

  • M1395

    Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group

  • M1396

    Patients on a therapeutic clinical trial